Mark A. Slater, Ph.D., CEO of the HonorHealth Research Institute, praised the adoption of the new radiation protection system.
“The issue of radiation exposure to physicians and catheterization laboratory staff has largely been ignored over the past 30 years. While we’ve seen dramatic technological advances in heart treatments, there have been few improvements in our ability to protect our physicians and nurses from the deleterious effects of radiation exposure,” said Dr. Slater, who also is HonorHealth’s vice president of research.
Ad Statistics
Times Displayed: 19596
Times Visited: 366 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
“The JSCAI article essentially demonstrates that there is a dramatic, statistically significant reduction in radiation exposure to staff using the Protego® system,” added Dr. Slater. “Accelerating medical innovation to enhance safety, quality of care, and patient outcomes is core to the mission of HonorHealth Research Institute.”
Dr. John Neil, HonorHealth’s executive vice president, chief physician executive and network strategy officer, was a practicing clinical vascular and interventional radiologist for two decades.
“The challenge of radiation exposure to those who work in the interventional lab is an issue that hits very close to home,” Dr. Neil said. “I am proud and appreciative of the groundbreaking work done by Dr. Rizik and the team at HonorHealth. Our Mission is to improve the health and well-being of those we serve. That includes protecting the health and well-being of those who dedicate their careers to saving lives and caring for others.”
Also contributing to this study from the HonorHealth Research Institute were: Dr. Robert D. Riley; Dr. Robert F. Burke; Sabrina R. Klassen; Ariana M. Nigoghosian; Kevin P. Gosselin, Ph.D.; and Dr. James A. Goldstein. Dr. Goldstein is an equity owner and board member of ECLS Inc., which licenses technology to Image Diagnostics Inc., which makes the Protego shield.
About the HonorHealth Research Institute
HonorHealth Research Institute is an international destination that is at the forefront of providing patients with a better quality of life through access to clinical trials and innovative treatment options. Headquartered in Scottsdale, Arizona, the institute’s team of physicians and researchers collaborate with experts from across the nation to offer life-changing therapies, drugs and devices. At the HonorHealth Research Institute, patients have access to tomorrow’s innovations, today.
Back to HCB News
